Nikhil Pereira Kamath
About Nikhil Pereira Kamath
Chief Business Officer at ProKidney
In 2023, Nikhil Pereira-Kamath joined ProKidney as Vice President of Business Development & Innovative Solutions and now holds the title of Chief Business Officer. His role involves leading business strategy and driving innovative solutions within the company. His focus is on expanding and developing strategies to enhance ProKidney's market presence and technological advancements in kidney healthcare.
Previous Leadership at Africa Healthcare Network
Nikhil Pereira-Kamath co-founded Africa Healthcare Network (AHN) in 2015, which has grown to become the largest independent provider of dialysis and kidney care in sub-Saharan Africa. He initially served as Chief Executive Officer and later became the Executive Chairman of AHN. Under his leadership, AHN expanded to over 500 employees and established 45 dialysis centers across four countries in sub-Saharan Africa.
Career Beginnings at Morgan Stanley and Berkshire Partners
Nikhil Pereira-Kamath began his career as an analyst at Morgan Stanley in its Healthcare Investment Banking division. In this role, he covered large pharma, biotech, and pharma services. Following this, he worked at Berkshire Partners, where he focused on investing in and growing companies across various sectors, including healthcare. These roles laid the foundation for his expertise in healthcare investment and business development.
Educational Background: Princeton University and Harvard Business School
Nikhil Pereira-Kamath received a B.A. in Economics with a Certificate in Finance from Princeton University. He furthered his education by earning an MBA from Harvard Business School. These academic achievements provided him with a solid foundation in economics, finance, and business management, fueling his subsequent professional endeavors in the healthcare sector.
Membership and Entrepreneurship
Nikhil Pereira-Kamath is a member of the International Society of Nephrology’s inaugural Emerging Leaders Program, highlighting his contributions to the field of nephrology. Additionally, he is recognized as an Endeavor Entrepreneur, which signifies his commitment to high-impact entrepreneurship and his role in driving innovation and growth in healthcare services.